Total planned funding: $152,290,906
Allocations
Countries/Regions
| India | $152,290,906 |
Organizational Types
| Unknown | $85,273,998 |
| NGO | $31,643,141 |
| Own Agency | $18,555,372 |
| University | $9,141,895 |
| Implementing Agency | $3,100,000 |
| Multi-lateral Agency | $1,760,000 |
| Host Country Government Agency | $939,200 |
| Private Contractor | $750,000 |
| Other USG Agency | $627,300 |
| FBO | $500,000 |
Program Areas
| Governance and Systems | $59,532,674 |
| Prevention | $40,749,333 |
| Care | $22,061,384 |
| Management and Operations | $14,182,694 |
| Testing | $9,382,308 |
| Treatment | $6,382,513 |
Budget Codes
| OHSS: Health Systems Strengthening | $33,189,998 |
| HVSI: Strategic Information | $21,737,438 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $21,302,387 |
| HBHC: Care: Adult Care and Support | $14,522,920 |
| HVMS: Management and Operations | $14,182,694 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,677,931 |
| HVCT: Testing: HIV Testing and Counseling | $9,382,308 |
| HTXS: Treatment: Adult Treatment | $6,139,289 |
| HLAB: Laboratory Infrastructure | $4,605,238 |
| HKID: Care: Orphans and Vulnerable Children | $4,566,921 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,852,484 |
| HVTB: Care: TB/HIV | $2,338,220 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,173,093 |
| HMBL: Biomedical Prevention: Blood Safety | $1,733,438 |
| PDCS: Care: Pediatric Care and Support | $633,323 |
| PDTX: Treatment: Pediatric Treatment | $243,224 |
| HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$84,649,509
Countries/Regions
USG Aggregated Agencies:
$11,405,789
Countries/Regions
FHI 360:
$8,859,571
Countries/Regions
Voluntary Health Services:
$6,200,000
Countries/Regions